Cardiovascular Medicine
Cardiovascular Medicine Faculty
![]() |
Jamie Beth Conti, M.D., F.A.C.C Division of Cardiovascular Medicine Professor of Medicine, Interim Chief Director, Clinical Cardiac Electrophysiology Program Director, Clinical Cardiac Electrophysiology and General Cardiovascular Diseases e-mail: contijb@medicine.ufl.edu 352-392-2469 |
Training:
| Degree Program |
Institution | Field/Specialty |
| AB | Harvard University | Biology |
| MD | University of Florida School of Medicine | |
| Residency | Emory University | Internal Medicine |
| Fellowship | University of Florida | Cardiovascular Medicine |
Academic Interests:
Dr. Conti is primarily involved in intracardiac device trials. She directs both the clinical cardiac electrophysiology fellowship as well as the general cardiovascular diseases fellowship.
Clinical Interests:
Arrythmia management, implantable devices, pregnancy and arrhythmias
Representative Publications:
- Sears, S.F., Vazquez Sowell, L., Kuhl, E.A., Handberg, E., Kron, J., Aranda, J.A.,& Conti, J.B. (2006). Quality of death: Implantable cardioverter defibrillators and proactive care. Pacing and Clinical Electrophysiology, 6, 637-642.
- Naccarelli G, Conti JB, DiMarco JP, Tracy CM. Task Force 6: Training in Specialized Electrophysiology, Cardiac Pacing, and Arrhythmia Management. J Am Coll Cardiol 2006:904-910.
- 3. Sears, S.F., Shea, J.B., & Conti, J.B. (2005). The cardiology patient page: How to respond to an ICD shock. Circulation, e380-e383.
- Whang, W., Albert, C.M., Sears, S.F., Lampert, R., Conti, J.B., Wang, P.J., Singh, J.P., Ruskin, J.M., Muller, J.E., Mittleman, M.A. for the TOVA investigators. (2005). Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: Results from the Triggers of Ventricular Arrhythmias (TOVA) Study. Journal of the American College of Cardiology, 45, 1090-1095.
- Aranda, J., Woo, G.W., Schofield, R., Handberg, E., Hill, J., Curtis, A.B., Sears, S.F., Goff, S.J., Pauly, D., & Conti, J.B. (2005). Management of heart failure after cardiac resynchronization therapy: Integrating advanced heart failure treatment with optimal device function. Journal of the American College of Cardiology, 46, 2193-2198.
Visit Pubmed for full list of publications
